Post

Final report says UK infected blood scandal “should have been avoided”  

The final report from the seven-year inquiry into the UK infected blood scandal has been published today, concluding that patients …

Amgen and AstraZeneca ponder label expansion for Tezspire in COPD

Amgen and AstraZeneca have highlighted the potential of Tezspire (tezepelumab) in chronic obstructive pulmonary disease (COPD) in a subgroup of …

UK clinical trials industry tackles recent changes in the sector

The UK clinical trial landscape has undergone vast changes post the Covid-19 pandemic and Brexit, while the country is actively …

Cervical cancer elimination in the UK is within sight with HPV vaccine

Cervical cancer is a serious condition but can be prevented with the human papillomavirus (HPV) vaccine. A recent study in …

How to identify and remove CNS assessment errors to avoid jeopardising a trial

WCG Clinical reports that failure rates for clinical trials involving the central nervous system (CNS) exceed 85% during Phases II …